Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST

K-Number: K023712 · 2003-01-31

ApplicantAdvantage Diagnostics Corp.
Decision Date2003-01-31
Product CodeDKZ
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST is the device name listed in this FDA 510(k) record. The listed applicant is Advantage Diagnostics Corp.. It received FDA 510(k) clearance on 2003-01-31 under 510(k) number K023712. The device is classified under product code DKZ. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST?

ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST is a medical device that received FDA 510(k) clearance on 2003-01-31. The listed applicant is Advantage Diagnostics Corp.. The 510(k) number is K023712.

When did ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST receive FDA 510(k) clearance?

ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST received FDA 510(k) clearance on 2003-01-31, under 510(k) number K023712.

Who is the listed applicant for ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST?

The FDA 510(k) record lists Advantage Diagnostics Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST?

The FDA product code for ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST is DKZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Advantage Diagnostics Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K013778PEACE OF MIND HOME DRUG TESTK011962ADVANTAGE MARIJUANA (THC) AND COCAINE HOME DRUG TESTK010921ADVANTAGE MARIJUANA (THC) HOME DRUG TESTK003708ADVANTAGE THC/COCAINE TESTK001567ADVANTAGE THC TESTK994227ADVANTAGE HCG TEST (URINE/SERUM)

View all 10 devices →

Related Devices (Code: DKZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K240670DRI Ecstasy Plus AssayMicrogenics CorporationK233019AllTest Multi-Drug Rapid Test Cup; AllTest Multi-Drug Rapid Test Panel; AllTest Multi-Drug Rapid Test Cup Rx; AllTest Multi-Drug Rapid Test Panel RxHangzhou AllTest Biotech Co., Ltd.K231137Xenta Drug Screen Cup, Xenta Drug Screen DipcardXenta Biomedical Science Co., Ltd.K200363Quidel Triage® TOX Drug Screen, 94600Quidel Cardiovascular, Inc.K191099Atlas Multi-Drugs Screening Test Cup, Atlas Multi-Drugs Screening Test PanelAtlas MedicalK182719Quidel Triage TOX Drug Screen, 94600; Quidel Triage® MeterProQuidel Cardiovascular, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑